Revised Assessments of Correlation Between Prescribed Medications and Forensic Toxicology Findings in Sweden
By
Heidi Taipale
Jari Tiihonen
Antti Tanskanen
Jonas Forsman
September 24, 2026
Clinical Scorecard: Revised Assessments of Correlation Between Prescribed Medications and Forensic Toxicology Findings in Sweden
At a Glance
Category Detail
Condition Forensic Toxicology and Pharmacotherapy Assessment Key Mechanisms Utilization of PRE2DUP for modeling drug exposure from dispensing records and comparison with toxicological findings. Target Population Individuals investigated for forensically related deaths in Sweden. Care Setting Forensic Medicine and Pharmacoepidemiological Research
Key Highlights
Updated analysis improved agreement metrics between modeled drug exposure and toxicological results. Exclusion of inconsistent testing periods refined the dataset and enhanced predictive performance. Cardiovascular drugs showed the most significant improvements in adherence and agreement metrics. Guideline-Based Recommendations
Diagnosis
Utilize forensic toxicology findings as a reference standard for assessing medication exposure. Management
Apply the PRE2DUP method for reconstructing continuous periods of drug exposure in forensic investigations. Monitoring & Follow-up
Regularly assess the consistency of toxicological testing methods to ensure reliable results. Risks
Be aware of potential misclassification of medication exposure due to inconsistent testing during hospitalization. Patient & Prescribing Data
Individuals with forensically investigated deaths linked to prescription records.
Certain drug classes, particularly cardiovascular medications, showed notable improvements in adherence metrics.
Clinical Best Practices
Ensure comprehensive data linkage between toxicology databases and prescription registries. Regularly update methodologies to reflect improvements in analytical techniques and testing consistency. Related Resources & Content
